Concerns about lamotrigine

Lancet Neurol. 2021 Jun;20(6):418-419. doi: 10.1016/S1474-4422(21)00132-0.

¹ School of Public Health, Université de Montréal, Montreal, QC, Canada.
² Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands; Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands; UCL Queen Square Institute of Neurology, London WC1N 3BG, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
³ Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands.
⁴ School of Public Health, Université de Montréal, Montreal, QC, Canada; Department of Neurosciences, Université de Montréal, Montreal, QC, Canada; Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands.
⁵ Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands; Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands; UCL Queen Square Institute of Neurology, London WC1N 3BG, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK. Electronic address: l.sander@ucl.ac.uk.

No abstract available

Publication types